Skip to main content
. 2019 Aug 20;20(4):3555–3564. doi: 10.3892/mmr.2019.10592

Figure 4.

Figure 4.

Effect of Sr-CaS on the tibia bone defects. The tibia bone defects as detected by hematoxylin and eosin staining after treatment with 0, 5 or 10% Sr-CaS for (A) 4 weeks and (B) 8 weeks. Masson staining was used to help determine the severity of the bone defects after they had been treated with 0, 5 or 10% Sr-CaS for (C) 4 weeks and (D) 8 weeks. Scale bar, 2,000 µm. Sr, strontium; CaS, calcium sulphate.